Letter from Dr Graham Winyard, Department of Health, to NHS Trust Medical Directors, re New Variant CJD - Patients who have received implicated blood products. Outlines the advice given to the Department of Health from ethics experts and other advisory bodies on informing patients who have received nvCJD-implicated blood components or products